- No mas: Principal bans Spanish language in intercom announcement
- Hacking software could put ‘zombie drone army’ in user’s hands
- Support for stricter gun laws drops: poll
- 10 whales dead, 41 others stranded in Everglades
- John Boehner faces bipartisan pressure to allow gay-rights vote
- Martin Bashir resigns from MSNBC over ‘ill-judged’ comments about Sarah Palin
- Rep. Duncan Hunter: While Obama prays for Iranian change, U.S. should ready its nukes
- Best company ever? Veteran Beer Co. exists to employ vets, provide quality beer
- Iran official: Sanctions ‘utterly failed’ to stop nuclear program
- ‘Black Santa’ display at IU sparks student outrage
Latest Pfizer Items
Lipitor is so valuable that Pfizer is practically paying people to keep taking its blockbuster cholesterol medicine after generic competition hits the U.S. market this week.
Federal health scientists say Pfizer's best-selling vaccine, Prevnar 13, is at least as effective as rival Merck's at helping prevent sometimes deadly infections in adults.
Federal health officials say Pfizer's anti-smoking drug Chantix did not increase psychiatric problems like depression and suicidal thoughts in two studies, though the findings are not definitive.
A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.
Michael E. Horowitz, President Obama's nominee as the Justice Department's top watchdog, has earned more than $4 million since last year as an attorney representing the likes of Pfizer Inc., Dow Chemical Co. and Cablevision Systems Corp. But he is keeping the identities of nearly a dozen other clients secret on newly filed ethics forms.
Pfizer Inc.'s just-approved Xalkori, the first new medicine in several years for deadly lung cancer, shows the value of a new research standard: precisely targeting rare diseases linked to gene variants.
The Food and Drug Administration has approved a new Pfizer drug for a subset of lung cancer patients with a particular genetic mutation.
Drug maker Pfizer Inc. says it has begun paying victims and their families affected by its fatal 1996 meningitis study in northern Nigeria.